A new FDA-approved painkiller isn't set to hit pharmacy shelves until next month, but critics are already warning that popping just two pills could be lethal.
Zohydro, which the FDA gave the green light in October against the advice of its advisory panel, will serve as a powerful pain pill for those who can't get relief from what's already out there.
It contains the same basic ingredient (hydrocodone) as Vicodin, but it has 5 to 10 times the power, Forbes noted, and without the added acetaminophen.
As an expert on the advisory board who voted "no" told NBC News, that acetaminophen deters savvy addicts from loading up on Vicodin for fear of liver damage.
Like OxyContin, Zohydro is a "pure narcotic"; but unlike OxyContin, the Zohydro set to be released isn't tamper resistant, and can easily be crushed, then snorted or injected.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app